← Back to Clinical Trials
Recruiting NCT06774586

NCT06774586 Study of the Characteristics of the Vascular Wall in Pediatric Age

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06774586
Status Recruiting
Phase
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition Cardiovascular Diseases
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2024-06-18
Primary Completion 2030-12-31

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2024-06-18 with a primary completion date of 2030-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

With this study, we want to investigate the characteristics of the blood vessel wall and study cardiovascular risk in children and adolescents, whether or not they have heart disease, by subjecting patient to a noninvasive diagnostic examination with an innovative medical device called VICORDER©.

Eligibility Criteria

Inclusion Criteria: * Patients from 6 to 17 years of age (extremes included) being treated in the Outpatient Departments of Emergency Pediatrics or admitted to the Department of Emergency Pediatrics * Patient cooperation during the performance of the examination. * Obtaining informed consent from the parent/legal guardian Exclusion Criteria: * Behavioral disorders or severe cognitive retardation, extreme agitation, or other factors that may impair the proper performance of the examination. * Anatomical alterations or presence of device or local pathology that conflicts with the placement of the VICORDER© cuffs.

Contact & Investigator

Central Contact

Marianna Fabi, MD

✉ marianna.fabi@aosp.bo.it

📞 0512143012

Principal Investigator

Marianna Fabi, MD

PRINCIPAL INVESTIGATOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Frequently Asked Questions

Who can join the NCT06774586 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06774586 currently recruiting?

Yes, NCT06774586 is actively recruiting participants. Contact the research team at marianna.fabi@aosp.bo.it for enrollment information.

Where is the NCT06774586 trial being conducted?

This trial is being conducted at Bologna, Italy.

Who is sponsoring the NCT06774586 clinical trial?

NCT06774586 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Marianna Fabi, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology